Search

everythinglearnresearchcommunity

for

Search:↓

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

JAK inhibitors may reverse early hair loss, but prolonged inflammation can cause permanent hair loss.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Targeting IL-17 could help treat pattern hair loss.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Apremilast did not work for treating severe alopecia areata.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Cancer treatments often cause skin, nail, and hair problems.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.